Therapeutically fed cholesterol does not aggravate EAE lesions. a) Clinical score of mice with EAE, when cholesterol feeding started therapeutically with the onset of symptoms (n=8-9 mice). b) Histopathological assessment of lumbar spinal cord sections as done in prophylactic cholesterol feeding experiments (Fig. 1) . LFB/PAS staining was used to determine the lesion area and number of lesions per section. Immuno-labeling for myelin basic protein was used to determine the percent of myelinated area within a lesion. On sections immuno-labeled for APP, the number of axonal speroids per square mm white matter area was counted, as a readout of axonal damage. Unpaired student's t-test revealed significantly less axonal damage in cholesterol fed animals (*, P<0.05). Sections triple stained for microglia / macrophages, T cells, and astrocytes (Iba1-CD3-GFAP triple immuno-labeling) were used to assess the cellular composition of lesions. Bars represent mean values (n=4-6 animals) with individual data points. c) Absolute number of abTCR/CD4 and abTCR/CD8 T cells and CD45/CD11b myeloid (macrophages/microglia) cells per gram spinal cord was determined by flow cytometry from mice fed normal chow or cholesterol enriched chow (n=3 animals). Bars represent means with individual data points.
Immune cell infiltration and the inflammatory milieu in EAE. a) Illustration of time points of analysis at the peak of clinical symptoms (16-18 dpi) and at remission (28 dpi), showing the clinical score of mice with EAE fed normal chow (bue) or cholesterol enriched chow (red). b) Absolute number of abTCR/CD4 and abTCR/CD8 T cells and CD45/CD11b myeloid (macrophages/microglia) cells per gram spinal cord was determined by flow cytometry from mice fed normal chow or cholesterol enriched chow (n=8-10 animals, 2 independent experiments). Bars represent mean values with individual data points. One-way ANOVA with Tukey's post test revealed significantly less infiltration by CD4 T cells and reduced density of myeloid cells (microglia / macrophages) during remission (*, P< 0.05). c) Quantitative RT-PCR analysis to assess the inflammatory milieu in spinal cord lysates of mice fed normal chow or chow supplemented with cholesterol at peak of clinical symptoms and in remission, determining the expression of IL2, IL17, IFNg, TNF, GM-CSF, and MHC-II. Values were normalized to chow fed mice. Bars represent the means (n=7 animals at peak, n=9 animals in remission) with individual data points. Significance of cholesterol supplementation on expression of individual genes was assessed by student's t tests (*, P<0.05; **, P<0.01; ***, P<0.001). Normal liver function in cuprizone treated animals. Activity of a) AST (aspartate transaminase), b) ALT (alanine transaminase), and c) GLDH (glutamate dehydrogenase) were determined in serum from mice after 6 weeks cuprizone with or without cholesterol supplementation (n=5-6 animals) and own untreated controls (n=4). Median with 2.5th -97.5th percentiles were plotted together with published reference intervals (AST n=7, ALT n=5, GLDH n=5; Jackson Laboratory mouse phenome database (Supplementary Refs. 1, 2)). Representative electron micrographs of the corpus callosum of mice (a) that were chronically treated with cuprizone (12 weeks) with or without cholesterol chow or (b) were treated according to the "induced remyelination" paradigm (demyelination with cuprizone in normal chow for four weeks, followed by remyelination for 1 week with or without cholesterol chow, 4+1). Scale bars, 1 µm. c) G-ratio analysis and mean g ratio in the corpus callosum of mice treated according to the "induced remyelination" paradigm (4+1) showing individual data points and mean g-ratios of cuprizone treated mice with and without cholesterol supplementation (n=4 animals) and untreated control mice (n=3 animals; 80-100 myelinated axons per animal). Representative images of proliferating OPCs (PCNA positive, Olig2 positive) in the corpus callosum of mice in the "induced remyelination" paradigm (demyelination for 4 weeks, followed by remyelination for one week, 4+1) in the presence of absence of cholesterol supplementation (scale 50 µm).
Supplementary Figure 7.
Motor performance on running wheel. a) Treatment scheme of experimental cohorts. Mice in the "induced remyelination" paradigm (I, II) received cuprizone in normal chow for 4 weeks followed by normal chow with or without added cholesterol. Control groups (III, IV) did not receive cuprizone. A training wheel was placed into cages two weeks after the start of experiment for a duration of three weeks to improve cardiopulmonary and musculoskeletal strength. Mean maximum running speed (Vmax) of the last 7 days on the training wheel was set as reference (100%) for each individual animal. Then a complex wheel replaced the training wheel and percent Vmax for each individual was calculated (control groups III and IV; experimental groups see Fig. 5g ) which is a measure for bilateral sensorimotor coordination that likely involves the cerebellum and motor cortex and connecting white matter such as the corpus callosum. b) Vmax on training wheel is not influenced by dietary cholesterol supplementation. Mean Vmax of each day of the third week on training wheel of cohorts I and II (n=6 animals). c) Vmax on complex wheel is not influenced by dietary cholesterol in control groups (III, IV) without cuprizone (n=13 animals). 
